You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 36 No. 10, September 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Day Treatment and Psychotropic Drugs in the Aftercare of Schizophrenic Patients

A Veterans Administration Cooperative Study

Margaret W. Linn, PhD; Eugene M. Caffey, MD; C. James Klett, PhD; Gerard E. Hogarty, MSW; H. Richard Lamb, MD

Arch Gen Psychiatry. 1979;36(10):1055-1066.


Abstract

• Schizophrenic patients referred for day treatment at the time of discharge from ten hospitals were randomly assigned to receive day treatment plus drugs or to receive drugs alone. They were tested before assignment and at 6, 12, 18, and 24 months on social functioning, symptoms, and attitudes. Community tenure and costs were also measured. The ten day centers were described on process variables every six months for the four years of the study. Some centers were found to be effective in treating chronic schizophrenic patients and others were not. All centers improved the patients' social functioning. Six of the centers were found to significantly delay relapse, reduce symptoms, and change some attitudes. Costs for patients in these centers were not significantly different from the group receiving only drugs. More professional staff hours, group therapy, and a high patient turnover treatment philosophy were associated with poor-result centers. More occupational therapy and a sustained nonthreatening environment were more characteristic of successful outcome centers.



Author Affiliations

From the Veterans Administration Hospital and University of Miami School of Medicine (Dr Linn); the VA Central Office, Washington, DC (Dr Caffey); the VA Cooperative Studies Coordinating Center, Perry Point, Md (Dr Klett); the Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine (Mr Hogarty); and the Universtiy of Southern California School of Medicine, Los Angeles (Dr Lamb).


Footnotes

Accepted for publication Jan 23, 1979.

Reprint requests to the Veterans Administration Hospital, 1201 NW 16th St, Miami, FL 33125 (Dr Linn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interpretive Group Psychotherapy and Dependent Day Hospital Patients: a Preliminary Investigation
Temple et al.
Int J Soc Psychiatry 1997;43:116-128.
ABSTRACT  

Psychiatric Rehabilitation: Redefined for the 1990s
Bridges et al.
Int J Soc Psychiatry 1994;40:1-16.
 

Family Psychoeducation, Social Skills Training, and Maintenance Chemotherapy in the Aftercare Treatment of Schizophrenia: II. Two-Year Effects of a Controlled Study on Relapse and Adjustment
Hogarty et al.
Arch Gen Psychiatry 1991;48:340-347.
ABSTRACT  

Psychiatric Day Care: the Users' Perspective
Holloway
Int J Soc Psychiatry 1989;35:252-264.
ABSTRACT  

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger
Arch Gen Psychiatry 1987;44:660-669.
ABSTRACT  

Antipsychotic Effects of Pimozide in Schizophrenia: Treatment Response Prediction With Acute Dextroamphetamine Response
van Kammen et al.
Arch Gen Psychiatry 1982;39:261-266.
ABSTRACT  

Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in Schizophrenia: Further Exploration of the Dopamine Hypothesis of Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1982;39:275-281.
ABSTRACT  

Psychiatry
Freedman
JAMA 1980;243:2208-2210.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.